Short answer
Electromed, Inc. (ELMD) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Fiscal first-quarter results announced for period ended September 30, 2026.
Electromed, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal first-quarter results announced for period ended September 30, 2026
- Press release furnished as Exhibit 99.1, containing the substantive financial results
- Results announcement provides the latest operating update for Electromed investors
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation furnished as Exhibit 99.2
- Presentation intended for investor and analyst meetings
- Potential market relevance limited to management’s latest investor messaging and outlook
Item EX-99.1 · Exhibit EX-99.1
- Q1 FY2027 revenue $18.7M, up 10.6%, marking the 16th consecutive quarter of year-over-year growth
- Direct homecare revenue rose 17.6% to $17.5M, supported by 63 sales representatives and $1.109M annualized revenue per representative
- Operating income increased 30.7% to $3.5M, with operating margin expanding to 18.7% from 15.8%
- Gross margin reached 80.0%, while net income rose 29.3% to $2.8M, or $0.32 diluted EPS
- Share repurchases totaled $4.3M, reducing shares outstanding to 8.24M while leaving Electromed debt-free with $15.9M cash
Item EX-99.2 · Exhibit EX-99.2
- Investor presentation highlights TTM revenue $75.6M, operating income $14.7M, cash $15.9M, and zero debt as of September 30, 2026
- Q1 FY2027 revenue rose to $18.7M from $16.9M, while diluted EPS increased to $0.32 from $0.25
- Q1 gross margin expanded to 80.0% from 78.1%, supporting operating margin growth to 18.7% from 15.8%
- Bronchiectasis penetration remains low at approximately 16%, underpinning management’s estimated $3.1B HFCWO opportunity
- Growth priorities include sales-force expansion, payer coverage, pediatric and hospital adjacencies, and potential acquisitions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Electromed, Inc. 8-K filings
Get the next ELMD 8-K as it lands
Follow ELMD for push alerts, or ask the research agent what this filing means.